GSK’s Sir Philip Hampton appointed to lead Women on Boards review

Sir Philip Hampton, chair of pharmaceuticals giant GlaxoSmithKline, has been appointed to lead Women on Boards, an independent review into the representation of women in the executive level of FTSE 350 companies.
Mon, 8 Feb 2016

Sir Philip Hampton, chair of pharmaceuticals giant GlaxoSmithKline, has been appointed to lead Women on Boards, an independent review into the representation of women in the executive level of FTSE 350 companies.

The government announced in a statement this morning, Hampton, who is also a former chair of banking group RBS and retailer Sainsbury’s, will succeed Lord Davies as chair to spearhead the next phase of the review. Lord Davies launched the review back in February 2011.

The next stage will focus on building the pipeline for female executives and emerging non-executive directors, continuing the work already done on increasing board representation. This was one of the key recommendations from Lord Davies's latest report last year.

In his first move as chair, Sir Philip has appointed Dame Helen Alexander as his deputy chair. Dame Helen is chair of business information company UBM. There was no deputy chair previously.

  • Want to comment on this story? The Comment box is at the bottom of the page. Sorry for the glitch but just scroll right down and share your opinions!

 

APPOINTMENTS: 28 APRIL-2 MAY 2025

This week’s appointments include: Eames Consulting, Oyster, Starfish Search

People 28 April 2025

APPOINTMENTS: 7-11 APRIL 2025

This week’s appointments include: Aspen, Eames Consulting, Sydney Mitchell, the rec hub

People 10 April 2025

CONTRACTS & DEALS: 7-11 APRIL 2025

This week’s new contracts & deals include: AESC, Dosen

Contracts 10 April 2025

NEW TO THE MARKET: 7-11 APRIL 2025

This week’s new launches include: HRGO, Sowena Group

New to Market 10 April 2025
Top